|Bid||0.1900 x N/A|
|Ask||0.2000 x N/A|
|Day's Range||0.2000 - 0.2000|
|52 Week Range||0.1800 - 2.1500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Today announced that it has entered into Collaborative Research Agreement (the "Agreement") with the ...
MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological diseases, today announced that it has entered into Collaborative Research Agreement (the "Agreement") with the University of British Columbia ("UBC") focussing on Novel Therapies for Neurological Diseases.
Is pleased to announce it has successfully closed on the previously announced transaction to acquire ...